{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:37:09Z","timestamp":1781026629023,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","award":["213751"],"award-info":[{"award-number":["213751"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.neuropharm.2018.12.023","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T12:10:28Z","timestamp":1545221428000},"page":"192-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The active heroin metabolite 6-acetylmorphine has robust reinforcing effects as assessed by self-administration in the rat"],"prefix":"10.1016","volume":"150","author":[{"given":"Riccardo","family":"Avvisati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger Lise","family":"Bogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannike M.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vigdis","family":"Vindenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rg","family":"M\u00f8rland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Badiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Boix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.12.023_bib1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/sj.npp.1300834","article-title":"Dissociation of psychomotor sensitization from compulsive cocaine consumption","volume":"31","author":"Ahmed","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.12.023_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1124\/jpet.109.152462","article-title":"Increased locomotor activity induced by heroin in mice: pharmacokinetic demonstration of heroin acting as a pro-drug for the mediator, 6-monoacetylmorphine, in vivo","volume":"331","author":"Andersen","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00213-005-0030-7","article-title":"Effect of repeated administrations of heroin, naltrexone, methadone, and alcohol on morphine glucuronidation in the rat","volume":"182","author":"Antonilli","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.12.023_bib4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1124\/jpet.103.055467","article-title":"Repeated exposures to heroin and\/or cadmium alter the rate of formation of morphine glucuronides in the rat","volume":"307","author":"Antonilli","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrn3104","article-title":"Opiate versus psychostimulant addiction: the differences do matter","volume":"12","author":"Badiani","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130000569","article-title":"Conditioned place preference: what does it add to our preclinical understanding of drug reward?","volume":"153","author":"Bardo","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.12.023_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0149-7634(94)00021-R","article-title":"Conditioned place preference using opiate and stimulant drugs: a meta-analysis","volume":"19","author":"Bardo","year":"1995","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41593-018-0152-y","article-title":"What does dopamine mean?","volume":"21","author":"Berke","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib9","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.113.212035","article-title":"A monoclonal antibody specific for 6-monoacetylmorphine reduces acute heroin effects in mice","volume":"349","author":"Bogen","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1369-1600.2010.00298.x","article-title":"Pharmacokinetic modeling of subcutaneous heroin and its metabolites in blood and brain of mice","volume":"18","author":"Boix","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00213-008-1154-3","article-title":"Opposite environmental regulation of heroin and amphetamine self-administration in the rat","volume":"198","author":"Caprioli","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.12.023_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00213-007-0717-z","article-title":"Environmental modulation of cocaine self-administration in the rat","volume":"192","author":"Caprioli","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.12.023_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s002130050956","article-title":"Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans","volume":"143","author":"Comer","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.12.023_bib14","series-title":"The Life of the Heroin User. Typical Beginnings, Trajectories and Outcomes","author":"Darke","year":"2011"},{"key":"10.1016\/j.neuropharm.2018.12.023_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbr.2007.04.005","article-title":"Corticosterone fails to produce conditioned place preference or conditioned place aversion in rats","volume":"181","author":"Dietz","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib16","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2017.15971","article-title":"Underlying factors in drug overdose deaths","volume":"318","author":"Dowell","year":"2017","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pbb.2014.03.018","article-title":"3-Methoxynaltrexone is not a selective antagonist for the acute psychomotor stimulating effects of heroin and 6-monoacetylmorphine in mice","volume":"122","author":"Eriksen","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib18","series-title":"European Drug Report 2018: Trends and Developments. Luxembourg","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2018"},{"key":"10.1016\/j.neuropharm.2018.12.023_bib19","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1017\/S1461145714000169","article-title":"Role of 6-monoacetylmorphine in the acute release of striatal dopamine induced by intravenous heroin","volume":"17","author":"Gottas","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib20","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/bph.12305","article-title":"Levels of heroin and its metabolites in blood and brain extracellular fluid after i.v. heroin administration to freely moving rats","volume":"170","author":"Gottas","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib21","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0022-3565(25)11333-5","article-title":"Heroin, 6-acetylmorphine and morphine effects on threshold for rewarding and aversive brain stimulation","volume":"260","author":"Hubner","year":"1992","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tips.2013.01.004","article-title":"What's conditioned in conditioned place preference?","volume":"34","author":"Huston","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0091-3057(97)00010-5","article-title":"Dosage choices of rats for morphine, for heroin, and between morphine and heroin","volume":"58","author":"Hutto","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2018.12.023_bib24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0024-3205(83)90616-1","article-title":"Evidence from opiate binding studies that heroin acts through its metabolites","volume":"33","author":"Inturrisi","year":"1983","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib25","article-title":"The role of 6-acetylmorphine in heroin-induced reward and behavioral sensitization in mice","author":"Kvello","year":"2019","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/jpet.116.233510","article-title":"Pharmacological effects of a monoclonal antibody against 6-monoacetylmorphine upon heroin-induced locomotor activity and pharmacokinetics in mice","volume":"358","author":"Kvello","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib27","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0022-3565(24)29229-6","article-title":"Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans","volume":"299","author":"Marsch","year":"2001","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00213-011-2534-7","article-title":"Induction of morphine-6-glucuronide synthesis by heroin self-administration in the rat","volume":"221","author":"Meringolo","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.12.023_bib29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-1759(03)00109-1","article-title":"Identification of scFv antibody fragments that specifically recognise the heroin metabolite 6-monoacetylmorphine but not morphine","volume":"280","author":"Moghaddam","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.neuropharm.2018.12.023_bib30","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1007\/s00213-015-3877-2","article-title":"Differential vulnerability to relapse into heroin versus cocaine-seeking as a function of setting","volume":"232","author":"Montanari","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.12.023_bib31","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(07)60464-4","article-title":"Development of a rational scale to assess the harm of drugs of potential misuse","volume":"369","author":"Nutt","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2018.12.023_bib32","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.178.4064.984","article-title":"Blood-brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection","volume":"178","author":"Oldendorf","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.12.023_bib33","doi-asserted-by":"crossref","first-page":"e115696","DOI":"10.1371\/journal.pone.0115696","article-title":"Pharmacokinetic correlates of the effects of a heroin vaccine on heroin self-administration in rats","volume":"9","author":"Raleigh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.12.023_bib34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/00003088-200645040-00005","article-title":"Population pharmacokinetics of heroin and its major metabolites","volume":"45","author":"Rook","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1742-7843.2006.pto_233.x","article-title":"Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients","volume":"98","author":"Rook","year":"2006","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.tips.2004.12.007","article-title":"Why does the rapid delivery of drugs to the brain promote addiction?","volume":"26","author":"Samaha","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib37","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1007\/s00213-014-3490-9","article-title":"Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties","volume":"231","author":"Seleman","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.12.023_bib38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0006-2952(01)00689-X","article-title":"[mu] Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine","volume":"62","author":"Selley","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib39","doi-asserted-by":"crossref","first-page":"8406","DOI":"10.1523\/JNEUROSCI.1958-08.2008","article-title":"Dissociation between rewarding and psychomotor effects of opiates: differential roles for glutamate receptors within anterior and posterior portions of the ventral tegmental area","volume":"28","author":"Shabat-Simon","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","article-title":"The reinstatement model of drug relapse: history, methodology and major findings","volume":"168","author":"Shaham","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.12.023_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.54.1.1","article-title":"Neurobiology of relapse to heroin and cocaine seeking: a review","volume":"54","author":"Shalev","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3565(25)26259-0","article-title":"Subjective effects of heroin and morphine in normal subjects","volume":"136","author":"Smith","year":"1962","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.31887\/DCNS.2017.19.3\/rspanagel","article-title":"Animal models of addiction","volume":"19","author":"Spanagel","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0022-3565(25)32685-6","article-title":"Pharmacodynamics of subcutaneously administered diacetylmorphine, 6-acetylmorphine and morphine in mice","volume":"218","author":"Umans","year":"1981","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib45","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pbb.2006.08.010","article-title":"Conditioned place preference induced by morphine and morphine-6-glucuronide in mice","volume":"85","author":"Vindenes","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib46","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.pbb.2008.01.012","article-title":"Different time schedules affect conditioned place preference after morphine and morphine-6-glucuronide administration","volume":"89","author":"Vindenes","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-2999(99)00633-0","article-title":"Antagonism of heroin and morphine self-administration in rats by the morphine-6beta-glucuronide antagonist 3-O-methylnaltrexone","volume":"383","author":"Walker","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib48","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-3565(25)25802-5","article-title":"The pharmacologic effects of heroin in relationship to its rate of biotransformation","volume":"129","author":"Way","year":"1960","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.12.023_bib49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0022-3565(25)03379-8","article-title":"The enzymatic deacetylation of heroin and related morphine derivatives by blood serum","volume":"71","author":"Wright","year":"1941","journal-title":"J. Pharmacol. Exp. Therapeut."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818304118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818304118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:55:03Z","timestamp":1758437703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818304118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":49,"alternative-id":["S0028390818304118"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.12.023","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734678533.793555031","asserted-by":"object"}]},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The active heroin metabolite 6-acetylmorphine has robust reinforcing effects as assessed by self-administration in the rat","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}